| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.26 | 0.2 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.38 | 0.2 |